Akero Therapeutics, Inc.
Overview
Akero Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing treatments for serious metabolic diseases with high unmet medical needs. The company focuses on advancing its pipeline of innovative therapies designed to treat nonalcoholic steatohepatitis (NASH) and potentially other metabolic diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Akero Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Akero Therapeutics, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.